Editor
Tisagenlecleucel Beneficial for Youth With Refractory B-Cell ALL
January 31, 2018 (HealthDay News)
Single infusion provided durable remission with long-term persistence in pediatric, young adult patients
A single infusion of the anti-CD19...
Other Studies on CAR T-Cell Therapy
Here are some links to studies that have recently come out on CAR T-Cell. These are obtainable only by a paid subscription to the...
Investigating CAR T-Cell Therapy in Lymphoma
Stephen M. Ansell, MD. PhD. and Radhakrishnan Ramchandren, MD discuss the Zuma 1 trial on pretreated large cell lymphoma. The CAR T-cell treatment showed...
CAR-T cell therapy and what to look for in 2018
Dr. Cohen describes what to expect in 2018 in the area of CAR T cell therapy, one of the most exciting new modalities for...
VIDEO: CAR T-cell Therapy for Pediatric Leukemia: Sam’s Story
Published September 18, 2017
CAR T-cell therapy is a revolutionary immunotherapy treatment that supercharges a patient's own blood cells to seek out and destroy...
VIDEO: Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors
Published on August 31, 2011
Researchers at Penn's Abramson Cancer Center have molecularly engineered T-cells from patients with chronic lymphocytic leukemia and achieved an exceptional,...
July 12, 2017 – Novartis CAR-T Cell Therapy One Step Closer to FDA Approval
"The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted to recommend approval for CTL019, an experimental cancer drug that belongs to...
VIDEO: Dr. Roboz on Challenges With CAR T-cell Therapy in ALL
Published on Aug 4, 2017
Gail Roboz, MD, a professor of Medicine and director of the Clinical and Translational Leukemia Program at Weill Cornell Medicine/NewYork-Presbyterian...
VIDEO: CAR T-Cell Therapy in Head and Neck Cancer
Published on Jul 21, 2017
Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses CAR T-cell therapy for...
VIDEO: ZUMA1 trial of CD19 CAR T cells for aggressive NHL
July 6, 2017 (ecancer)
Dr Lin speaks with ecancer at EHA 2017 about clinical and biologic outcomes in patients with refractory aggressive Non-Hodgkin Lymphoma (NHL)...
